<?xml version="1.0"?>

<document>
	<title>Polypoid cervicitis in cystic fibrosis patients receiving oral
   contraceptives.</title>

	<author>Dooley-R-R.</author>
	<author>Braunstein-H.</author>
	<author>Osher-A-B.</author>

	<source>Am-J-Obstet-Gynecol. 1974 Apr 1. 118(7). P 971-4.</source>

	<abstract>Three of the 4 women in a cystic fibrosis clinic who used a combined
   form of oral contraceptive developed acute polypoid cervicitis.  In
   one woman, the polyp recurred on reinstitution of the medication.
   There was resolution of the polyp in each instance on
   discontinuation of the drugs.  In 2 of the 3 affected women, there
   was coincidental deterioration of respiratory status.  Therefore, it
   is suggested that cystic fibrosis patients who are using oral
   contraception be observed closely regarding pulmonary and
   gynecologic status.</abstract>

	<majorsubject>CERVICITIS: ci</majorsubject>
	<majorsubject>CERVIX-NEOPLASMS: ci</majorsubject>
	<majorsubject>CONTRACEPTIVES-ORAL: ae</majorsubject>
	<majorsubject>CYSTIC-FIBROSIS: co</majorsubject>
	<majorsubject>POLYPS: ci</majorsubject>

	<minorsubject>ADULT</minorsubject>
	<minorsubject>BIOPSY</minorsubject>
	<minorsubject>CERVICITIS: co</minorsubject>
	<minorsubject>CERVIX-NEOPLASMS: co, pa</minorsubject>
	<minorsubject>ETHINYL-ESTRADIOL: ae</minorsubject>
	<minorsubject>FEMALE</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>MEDROXYPROGESTERONE: ae</minorsubject>
	<minorsubject>NEUTROPHILS</minorsubject>
	<minorsubject>NORETHINDRONE: ae</minorsubject>
	<minorsubject>POLYPS: co, pa</minorsubject>
	<minorsubject>RESPIRATORY-INSUFFICIENCY: co</minorsubject>

	<reference>001   OPPENHEIMER EA        AM J OBSTET GYNECOL            108   673 970</reference>
	<reference>002   OPPENHEIMER EH        J PEDIATR                       77   991 970</reference>
	<reference>003   TAYLOR HB             JAMA                           202   637 967</reference>
	<reference>004   GOVAN ADT             J CLIN PATHOL                   22    84 969</reference>
	<reference>005   GALL SA               JAMA                           207  2243 969</reference>
	<reference>006   TALBERT JR            AM J OBSTET GYNECOL            105   117 969</reference>
	<reference>007   KYRIAKOS M            CANCER                          23    99 968</reference>
	<reference>008   GRAHAM J              OBSTET GYNECOL                  31   190 968</reference>
	<reference>009   MAQUEO M              AM J OBSTET GYNECOL             96   994 966</reference>
	<reference>010   BLAIR GWS             BIOCHEM J                       35  1039 941</reference>
	<reference>011   KOPITO LE             FERTIL STERIL                   24   499 973</reference>

	<citation>1   GREENSTEIN JS         CONTRACEPTION                   11   105 975</citation>
	<citation>2   WOOD RE               AM REV RESPIR DIS              113   833 976</citation>
	<citation>3   ANASTASIADIS P        GEBURTSHILFE FRAUENHEILKD       38    45 978</citation>
	<citation>4   FITZPATRICK SB        CHEST                           86   863 984</citation>
	<citation>5   STEAD RJ              THORAX                          42    59 987</citation>

</document>
